tirzepatide type 1 diabetes trial monotherapy in Chinese patients with early 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 (SURPASS-CN-MONO) Unveiling the Therapeutic Potential of
Pay in 4 interest-free payments of $7.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11


























